A new chemical compound has been making a big impression in the fight against cancer in recent years. Now it seems EBC-46, otherwise known as tigilanol tiglate, may also have immense potential for ...

CAR T cell therapy is one of the most promising new cancer treatments to emerge in recent years. It involves removing a patient's own immune T cells and engineering them to recognize specific targets ...

HIV has become a more manageable condition in recent years, but a full cure remains elusive. Now, scientists have found ...

PEPFAR has saved 25 million lives around the globe and is considered George W. Bush's greatest achievement. Donald Trump has left its future in doubt.

HB-500 is a next-generation therapeutic vaccine being developed in collaboration with Gilead Sciences, Inc. (Gilead) as a potential component of ...

An exciting collaboration between the Ragon Institute and the Jameel Clinic at MIT has achieved a significant milestone in leveraging artificial intelligence (AI) to aid the development of T cell ...

Curing HIV will be harder than curing cancer. Apart from a few 'miracle' cases, antiretrovirals only suppress HIV, they don't ...

Pseudoscience has recently been reemerging in the US. While much of it concerns vaccines, an "oldie" is again making the ...

The Trump administration has directed clinics in foreign countries that provide HIV medications paid for by the United States ...

That scientific creativity helped propel her to being named a top 40 finalist in the 84th Regeneron Science Talent Search — ...

A compound with the unpresuming designation of EBC-46 has made a splash in recent years for its cancer-fighting prowess. Now ...

A unique reaction in which antibodies bind to other antibodies may help scientists at Scripps Research better understand how ...